Vivo Bio Tech Limited (BOM:511509)

Market Cap	428.50M -51.2%
Revenue (ttm)	551.03M +12.3%
Net Income	-28.58M
EPS	-1.29
Shares Out	22.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,499
Open	19.72
Previous Close	19.33
Day's Range	18.00 - 19.72
52-Week Range	18.00 - 43.35
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Vivo Bio Tech

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory...

• Industry: Commercial Physical and Biological Research
• Founded: 1987
• Employees: 174
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 511509

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 23, 2026

Data Sources Report a data error